For Patients in Unmet Needs.

For patients in clear unmet needs in a wide range of conditions, MYCB1 Apotheek offers standardized medical cannabis extracts manufactured according to Good Manufacturing Practice (GMP) guidelines, available as prescription-only medicines*.

As there is a lack of scientific evidence on the efficacy of cannabinoid based products, MYCB1 has developed ALETTA ® a Real-World Data Management platform to conduct studies base on Real-World Evidence or just to have more informed medical decisions on cannabinoid treatments; on the side helping the patient in disease selfmanagment.

• The usage of ALETTA is free of charge for the patient and clinician.
  
  
• Patients can use an ALETTA mobile App available in App Store and Play Store, and the Doctor a desktop dashboard for statistical analysis. 
  
  
• MYCB1 is the first pharmacy in The Netherlands to be ISO27001 (information security management) and NEN7510 (informatie beveiliging in de zorg) certified, bringing protection of patient data to a complete new level. In addition, we are ISO 9001 and HKZ certified. 
  
  
• *MYCB1 cannabis oils are registered in the Z-index and authorized for prescription.
  
  
• MYCB1 does not provide unregulated, over-the-counter cannabidiol (CBD) products, manufactured from industrial hemp. Our only source for raw material (cannabis flowers) is the Office of Medicinal Cannabis from the Ministry of Health and Sports of The Netherlands.